Using bioinformatics to understand Alzheimer's disease and develop new treatments

Bioinformatics and Computational Biology Core (BCB)

NIH-funded research Indiana University Indianapolis · NIH-10950441

This study is looking at big sets of data about Alzheimer's disease to find new ways to treat it, so that patients can have better options for managing their condition.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionIndiana University Indianapolis NIH-funded
Lab location1 site (Indianapolis, United States)
Project IDNIH-10950441 on NIH RePORTER

What this research studies

This research focuses on leveraging bioinformatics and computational biology to analyze large datasets related to Alzheimer's disease (AD). By examining the complex biological processes involved in AD, such as protein abnormalities and immune responses, the project aims to identify potential drug targets and develop new therapeutic strategies. Patients may benefit from advancements in understanding the disease, which could lead to more effective treatments. The research is part of a collaborative effort involving multiple institutions to accelerate therapy development for Alzheimer's.

Who could benefit from this research

Good fit: Ideal candidates for this research include individuals diagnosed with Alzheimer's disease or those at risk due to advanced age.

Not a fit: Patients with other forms of dementia unrelated to Alzheimer's may not receive benefits from this research.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for Alzheimer's disease, improving the quality of life for patients.

How similar studies have performed: Previous research utilizing bioinformatics approaches has shown promise in identifying drug targets for Alzheimer's, indicating a potential for success in this area.

Where this research is happening

Indianapolis, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions Alzheimer disease dementiaAlzheimer syndrome
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.